PLACEHOLDER: Free shipping over $XX — confirm threshold

Topical cosmetics and devices only — not for injection

Cellular Sequence

Peptide Encyclopaedia

Approved medicineApproved medicine

Glutathione

Also known as GSH, γ-glutamyl-cysteinyl-glycine.

Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.

At-a-glance profile

Classification
Endogenous tripeptide antioxidant
Approval status
Approved medicine
Research status
Labelled indications are defined in product information.
Molecular formula
Insufficient reliable evidence identified.
Molecular weight
Insufficient reliable evidence identified.
Sequence
Glu-Cys-Gly. Licensed uses exist in specific presentations; high-dose IV ‘whitening’ vials are another matter.
Primary biological target
Insufficient reliable evidence identified.
Half-life
Insufficient reliable evidence identified.
Routes investigated
Insufficient reliable evidence identified.
Human evidence level
A — Approved clinical use / strong human evidence

What is it?

The body’s main thiol antioxidant. High-dose injectable glutathione sold for skin lightening is not an approved cosmetic here and is not sold.

Mechanism of action

Redox buffering and conjugation reactions.

Systemic redox change; IV use has been associated with serious adverse events when unregulated.

What is it being studied for?

  • Selected licensed supportive uses
  • Unapproved cosmetic IV markets

Investigational findings are not proven clinical benefits unless an authority has labelled that indication.

Evidence level

Overall human evidence grade: A · Approved clinical use / strong human evidence

Human research

Endogenous biochemistry is known; cosmetic IV evidence is poor and safety is not benign.

Preclinical research

Animal, cell and in-vitro findings are listed separately from human effects.

Textbook redox biology.

Doses reported in published research

This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.

Doses reported in human studies

Insufficient reliable evidence identified.

Preclinical / animal study dosing

Insufficient reliable evidence identified.

Pharmacokinetics

Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.

Safety

Anaphylactoid reactions and liver injury reports with unregulated IV use.

Unknowns. Absence of a published harm signal is not evidence of safety.

Contraindications. Do not use unlicensed IV glutathione.

Regulatory status

Ingredient/medicine status depends on presentation; research ‘GTT’ vials are not licensed IV therapy.

Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.

Citations

  1. [1] Encyclopaedia note

    Encyclopaedia note

For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.

Last reviewed 2026-09-13. Research areas: Skin & Hair, Healthy Ageing · Compare peptides